• Thumbnail for CanSino Biologics
    117.5430 CanSino Biologics (simplified Chinese: 康希诺生物; traditional Chinese: 康希諾生物; pinyin: Kāngxīnuò Shēngwù), often abbreviated as CanSinoBIO, is a Chinese...
    15 KB (1,091 words) - 19:31, 11 November 2023
  • Thumbnail for Convidecia
    COVID-19 that is also used as an inhaled booster. It was developed by CanSino Biologics, with Phase III trials conducted in Argentina, Chile, Mexico, Pakistan...
    36 KB (3,379 words) - 00:52, 31 December 2023
  • Thumbnail for Chen Wei (medical scientist)
    Institute of Biotechnology, the Academy of Military Medical Sciences, and CanSino Biologics to develop Convidecia. The development team registered a Phase 1 trial...
    15 KB (1,075 words) - 18:24, 19 February 2024
  • Thumbnail for Academy of Military Medical Sciences
    Uyghurs in China. During the COVID-19 pandemic, the AMMS partnered with CanSino Biologics to develop Convidecia. The development team, led by Chen Wei, registered...
    12 KB (1,000 words) - 22:12, 7 March 2024
  • Sputnik V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development...
    10 KB (796 words) - 15:33, 1 January 2024
  • Thumbnail for Sinopharm (company)
    COVID-19 vaccine is also an inactivated virus vaccine.[citation needed] CanSino Biologics Sinovac "中国医药集团有限公司主要领导调整" (in Chinese). Sinopharm. Archived from...
    17 KB (1,205 words) - 14:53, 8 November 2023
  • (NASDAQ:ZLAB; HKSE:9688), CanSino Biologics(SSE:688185; HKSE:6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar...
    9 KB (828 words) - 03:17, 5 February 2024
  • Thumbnail for Justin Trudeau
    reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5...
    220 KB (18,134 words) - 11:39, 26 March 2024
  • authorizes use of China's CanSino vaccine against COVID-19". Reuters. 15 June 2021. Retrieved 16 June 2021. "China's CanSino Biologics COVID-19 vaccine receives...
    318 KB (19,351 words) - 20:33, 14 March 2024
  • Thumbnail for History of COVID-19 vaccine development
    October 2022, China began administering an oral vaccine developed by CanSino Biologics using its adenovirus model. Despite the availability of mRNA and viral...
    122 KB (11,028 words) - 02:32, 27 January 2024
  • Thumbnail for Vaccine diplomacy
    Foreign Affairs of Mexico Marcelo Ebrard announced agreements with CanSino Biologics and Walvax to conduct clinical trials for vaccines from China, with...
    36 KB (3,258 words) - 05:56, 10 March 2024
  • October 2022, China began administering an oral vaccine developed by CanSino Biologics using its adenovirus model. Despite the availability of mRNA and viral...
    191 KB (21,884 words) - 08:58, 18 March 2024
  • Thumbnail for COVID-19 vaccination in Canada
    conduct clinical trials of a vaccine candidate by Chinese company CanSino Biologics, and plans to manufacture it at its facilities in Montreal once authorized...
    166 KB (13,886 words) - 09:34, 8 March 2024
  • Thumbnail for Ebola vaccine
    Academy of Military Medical Sciences and the private vaccine-maker CanSino Biologics. It contains a human adenovirus serotype 5 vector (Ad5) with the glycoprotein...
    66 KB (6,046 words) - 11:44, 12 December 2023
  • reached an exclusive deal with CanSino Biologics. However, due to deteriorating Canadian-Chinese relations, the Cansino deal fell through. On August 5...
    122 KB (13,732 words) - 02:06, 7 February 2024
  • Thumbnail for Sinovac Biotech
    has signed purchase agreements for 380 million doses from COVAX. CanSino Biologics Sinopharm "China's Vaccine Front-Runner Aims to Beat Covid the Old-Fashioned...
    19 KB (1,370 words) - 04:48, 12 October 2023
  • Thumbnail for COVID-19 pandemic in Canada
    conduct clinical trials of a vaccine candidate by Chinese company CanSino Biologics, and plans to manufacture it at its facilities in Montreal once authorized...
    188 KB (14,346 words) - 01:19, 29 March 2024
  • approved the emergency use of the Convidecia vaccine developed by CanSino Biologics. On 24 February 2021, Pakistan announced all coronavirus restrictions...
    191 KB (18,700 words) - 15:41, 3 March 2024
  • Thumbnail for Responses to the COVID-19 pandemic in June 2021
    Jamaluddin confirmed that refugee communities in Malaysia would receive CanSino Biologics' Convidecia vaccine; with the first shipment due to arrive in late...
    20 KB (1,658 words) - 00:56, 28 February 2024
  • Thumbnail for COVID-19 vaccination in Mexico
    the vaccine. The COVID-19 vaccine from the pharmaceutical company CanSino Biologics will be packaged in Querétaro, after the company requested from COFEPRIS...
    13 KB (1,010 words) - 21:47, 21 October 2023
  • Thumbnail for Chinese government response to COVID-19
    Biotech Group. The government also approved a vaccine developed by CanSino Biologics for use in the military. By mid-December, authorities said that over...
    188 KB (20,067 words) - 19:20, 18 January 2024
  • The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of...
    13 KB (1,517 words) - 13:17, 22 March 2023
  • Thumbnail for COVID-19 vaccination in Malaysia
    confirmed that refugee communities in Malaysia would be inoculated with CanSino Biologics' Convidecia vaccine. The first shipment is due to arrive in late July...
    295 KB (28,235 words) - 09:39, 8 March 2024
  • Thumbnail for COVID-19 vaccination in Singapore
    healthcare settings so people, who are not suitable to take the mRNA vaccines, can take the Sinovac vaccine. However, since the China-made vaccine is not part...
    30 KB (2,631 words) - 04:19, 28 March 2024
  • of Biological Sciences at the University of Montreal. Starting in June, the Ad5-nCoV vaccine, developed by the Chinese company CanSino Biologics (Tianjin...
    180 KB (17,227 words) - 15:36, 6 March 2024
  • Thumbnail for Shirō Ishii
    Shirō Ishii (category Japanese biological weapons program)
    application of biological weapons at Unit 731 in Manchukuo during the Second Sino-Japanese War from 1937 to 1945, including the bubonic plague attacks at Chinese...
    21 KB (2,306 words) - 23:20, 26 March 2024
  • Thumbnail for Responses to the COVID-19 pandemic in August 2020
    developed by American company Johnson & Johnson and Chinese companies CanSino Biologics and Walvax Biotechnology, with the aim of eventually securing doses...
    139 KB (12,849 words) - 09:34, 15 November 2023
  • Thumbnail for Unit 731
    Unit 731 (category Second Sino-Japanese War crimes)
    that engaged in lethal human experimentation and biological weapons manufacturing during the Second Sino-Japanese War (1937–1945) and World War II. It killed...
    128 KB (14,237 words) - 06:53, 28 March 2024
  • Thumbnail for Unit 543
    Unit 543 (category Second Sino-Japanese War crimes)
    Japanese military police. Japanese war crimes List of Japanese War Atrocities Kantogun Second Sino-Japanese War Hal Gold, Unit 731 Testimony, 2003 v t e...
    932 bytes (55 words) - 08:30, 20 January 2024
  • Unit Ei 1644 (category Second Sino-Japanese War)
    It had 12 branches and employed about 1,500 men.: 307  During the Second Sino-Japanese War, Unit Ei engaged in "producing on a mass scale lethal bacteria...
    9 KB (1,055 words) - 22:47, 13 January 2024